Loading
NUV-1511 is a small-molecule inhibitor from Nuvation Bio Inc., in registered phase 2 trials for prostate cancer, pancreatic ductal adenocarcinoma, ovarian cancer.
NUV-1511 is listed on ClinicalTrials.gov as an intervention in 1 registered phase 2 trial sponsored by Nuvation Bio Inc., in prostate cancer, pancreatic ductal adenocarcinoma, ovarian cancer. Described in the registry record as a small-molecule inhibitor; the trial entries below carry the sponsor's wording. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
Described in the registry record as a small-molecule inhibitor; the trial entries below carry the sponsor's wording.
1.NUV-1511 slips into a pocket on its target.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"NUV-1511" OR ABSTRACT:"NUV-1511") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about NUV-1511, not a curated reading list.
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer and the tags pipeline, registry-only.
Shares Ovarian cancer, Prostate cancer and the tags pipeline, registry-only.
Shares Ovarian cancer, Pancreatic ductal adenocarcinoma, Prostate cancer and the tag pipeline.
Shares Ovarian cancer and the tags pipeline, registry-only.
Shares Ovarian cancer and the tags pipeline, registry-only.
Shares Pancreatic ductal adenocarcinoma and the tags pipeline, registry-only.
Shares Ovarian cancer and the tags pipeline, registry-only.
Shares Ovarian cancer and the tags pipeline, registry-only.